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A new gated nanodevice design able to control cargo delivery 
using glucose as trigger and cyclodextrin-modified glucose 
oxidase as capping agent is reported.  
 Mass transport control at the nanometric level is a captivating 
area of research that has attracted the attention of scientists in the 
latest years. Especially, the development of gated systems able to 
retain a cargo and release it after the application of a stimulus has 
demonstrated to be an excellent approach for the development of 
smart nanodevices for advanced delivery applications.1 In this 
context, silica mesoporous supports are widely used as inorganic 
scaffolds thanks to their unique characteristics such as high 
homogeneous porosity, inertness, robustness, thermal stability, 
the presence of tunable pore sizes, homogeneous pore distribution 
and high loading capacity.2 Moreover, via decoration of the 
mesoporous material with a wide collection of organic moieties, 
linkers and capping agents, researchers have prepared nanovalves 
that can be triggered with target chemical3 (such as redox 
molecules, selected anions, pH changes and biomolecules) 
physical 4 (such as light, temperature or magnetic fields) and bio-
chemical (such as enzymes, antibodies, or DNA) stimuli.5  
In particular the development of enzyme-responsive bio-gated 
mesoporous silica nanoparticles is appealing. In previously 
reported examples tailor-made sequences anchored on the 
mesoporous support are hydrolized by target enzymes allowing 
the selective release of the entrapped cargo. However in these 
cases enzymes act as triggers but as far as we know there are not 
examples where enzymes were used as functional gating 
elements.6 In this context, and as a new approach, we envisioned 
the potential design of gated materials in which the enzymes 
could act as caps and the uncapping process would be triggered 
by the product obtained by the enzyme’s activity on a target 
substrate. The combination of the promising features of silica 
mesoporous supports as containers, enzymes as caps and 
substrates as trigger would result in a sophisticated but simple 
way to prepare selective substrate-responsive gated mesoporous 
materials for different applications. As a proof-of-concept we 
have selected herein glucose oxidase as capping enzyme and 
glucose as the substrate to trigger cargo release.  
 The designed capped support is depicted in Scheme 1. It is 
based on the use of mesoporous silica nanoparticles loaded with a 
suitable reporter (i.e. ruthenium bipyridine complex) and 
containing anchored methylbenzymidazole moieties on the pore 
outlets. The mesopores are then capped with an active CD-
modified-glucose oxidase (CD-GOx) through the formation of an 
inclusion complex between the cyclodextrins and the 
propylbenzymidazole group anchored to the solid support. The 
presence of the substrate glucose combined with the catalytic 
action of CD-GOx to produce gluconic acid was expected to 
induce protonation of the benzymidazole group that might result 
in the inclusion complex dethreating and the subsequent cargo 
release. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Solid S3 expected performance. 
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In their work, they reported a saccharide-responsive controlled 
release of insulin and cAMP using phenylboronic acid-
functionalized silica mesoporous nanoparticles.6 However, this 
later system was based in a simple displacement reaction yet no 
enzymes were used in its design. 
 In order to prepare the gated nanodevice, silica mesoporous 
(MCM-41-type) nanoparticles (ca. 100-150 nm) were selected as 
inorganic scaffold. The MCM-41 support was loaded with a 
suitable dye ([Ru(bpy)3]Cl2) and the external surface was 
functionalized with 3-iodopropyltrimethoxysilane (solid S1). 
Then, a nucleophilic substitution reaction of the anchored 3-
iodopropyl moiety with benzimidazole resulted in a solid 
functionalised with 1-propyl-1-H-benzimidazole groups (solid 
S2).  
These intermediate supports (S1 and S2) were characterized 
using standard procedures (see Supporting Information). X-ray 
diffraction pattern of S2 (Figure 1) shows the mesoporous 
characteristic (100) diffraction peak indicating that the loading 
process with the dye and the further functionalization to obtain 
the benzimidazole domains have not modified the structure of the 
mesoporous scaffolding. Moreover, contents of 0.48 mmol g-1 
SiO2 of dye and 0.54 mmol g-1 SiO2 of benzimidazole on solid 
S2 were determined by elemental analysis and thermogravimetric 
studies. 
Figure 1. Powder X-ray diffraction pattern of a) MCM-41 as made, b) 
calcined MCM-41, c) solid S1 and d) solid S2 showing the typical 
reflections of the MCM-41 hexagonal array. TEM representative images 
of e) calcined MCM-41 and f) solid S2 showing the typical porosity of the 
MCM-41 mesoporous matrix. 
 For the preparation of the final gated material, CD-GOx was 
synthesized as previously reported7 and a mixture of S2 and CD-
GOx in water at pH 7.5 was stirred for 24h. After that time, the 
capped solid was centrifuged and washed with water at pH 7.5 
three times to obtain the orange final solid S3. (see Supporting 
Information for further details)   
 In order to test the gating properties of the solid, portions of 
150 µL of a suspension of S3 (6.7 mg mL-1) were diluted with 3 
mL of water at pH 7.5 in the presence of glucose (0.1 molL-1) and 
stirred for a certain time. As a control experiment another portion 
of 150 µL of the suspension of S3 was diluted in the same 
proportion and stirred. During the experiments, at a given time, 
0.3 mL of each suspension was filtered, and the absorbance at 
453 nm of the released [Ru(bpy)3]Cl2 was measured.  
 The delivery kinetics profile of the ruthenium dye in the 
presence and absence of glucose is shown in Figure 2. In absence 
of glucose (curve a) solid S3 shows a very poor dye release, 
indicating tight pore closure. On the other hand, the delivery of 
the dye is induced when glucose is present in the solution (curve 
b) due to displacement of the CD-GOx as consequence of CD-
GOx-induced oxidation of glucose to gluconic acid and 
protonation of the benzimidazole group. Thus, the presence of 
glucose allows the release of 51% of the entrapped dye. 
Additionally, the figure also shows how release from the capped 
system can be triggered on command by adding glucose at a 
certain time (curve c). 
 The obtained results confirmed the triggering event hypothesis; 
i.e. whereas solid S3 displayed no release, the presence of the 
substrate of the enzyme acting as cap induced the delivery of the 
entrapped guest. Moreover, to confirm that the opening protocol 
was due to protonation of the benzimidazole which induced the 
dethreating of the inclusion complex, pH changes in the final 
aliquots were measured. Thus, only in the experiments in which 
glucose was present a change from pH 7.5 to pH < 5.2 was 
observed confirming the enzyme-mediated conversion of glucose 
in gluconic acid.  
Figure 2. Release profile of [Ru(bpy)3]Cl2 from solid S3 at pH 7.5 a) in 
the absence of glucose, b) in the presence of glucose c) with glucose 
addition at 30 min. 
 On the other hand, we believe that solid S3 or similar systems 
could be of application in the development of glucose-induced 
delivery systems or in the design of colorimetric probes for 
glucose determination. In this context, and as a further step in the 
characterization of the delivery system, the response of the hybrid 
material S3 as a function of the glucose concentration was studied 
and the results are illustrated in Figure 3. From these data a linear 
release of the dye from S3 in the 1x10-2-1x10-4 molL-1 glucose 
concentration range was found. Moreover a detection limit of 
glucose of 1.5x10-4 molL-1 was calculated which was in the range 
of other glucose-responsive reported detection systems.8 Taking 
into account that the general range of blood glucose concentration 
in healthy and diabetic humans is about 3–8 mM and 9–40 mM, 
respectively,9 we can envision the potential of this enzyme-gated 
systems for the design of chromo-fluorogenic probes for glucose 
detection. 
Figure 3. Released dye from solid S3 in the presence of different glucose 
concentrations. 
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  Moreover, as it is well-known enzymes are selective catalytic 
centres. In our case, although numerous sugars and derivatives of 
glucose have been reported to be substrates of GOx, the enzyme 
shows far greater activity with glucose. In this scenario, the 
selectivity in the opening protocol in S3 was tested in the 
presence of different saccharides such as mannose, fructose, 
galactose, maltose and saccharose at a concentration of 1x10-3 
molL-1 and following the same described procedure. As it can be 
seen in Figure 4 a selective uncapping was observed in the 
presence of glucose confirming the selective triggering.  
 
Figure 4. Released dye from 1 mg of solid S3 in the presence of different 
analytes (1x10-3 molL-1). 
 In summary, we have reported a new approach for the 
development of gated materials using enzymes. In this proof-of-
principle, the mesoporous material is capped with an active CD-
modified-glucose oxidase (CD-GOx) through the formation of 
inclusion complexes between the cyclodextrins and the 
propylbenzymidazole group anchored to the solid support. In the 
presence of glucose as target substrate a cascade response results 
in a delivery of the entrapped cargo. In particular, CD-GOx 
converts glucose to gluconic acid which induces the protonation 
of benzimidazole which results in a dethreating of the inclusion 
complex and delivery of the dye. The approach is simple and 
versatile and may allow to inspire the design of high selective on-
command delivery systems based on enzyme’s activity on target 
substrates for different applications. 
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